Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
<p style="text-align:justify;"> <b>Background:</b> To investigate disease progression the first 12 months after diagnosis in children with type 1 diabetes negative (AAB negative) for pancreatic autoantibodies [islet cell autoantibodies(ICA), glutamic acid decarboxylase a...
Κύριοι συγγραφείς: | Pörksen, S, Laborie, L, Nielsen, L, Louise Max Andersen, M, Sandal, T, De Wet, H, Schwarcz, E, Aman, J, Swift, P, Kocova, M, Schönle, E, de Beaufort, C, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Mortensen, H, Hansen, L, Njølstad, P |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
BioMed Central
2010
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group
ανά: Porksen, S, κ.ά.
Έκδοση: (2008) -
Monogenic diabetes
ανά: Kavvoura, FK, κ.ά.
Έκδοση: (2018) -
Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
ανά: Davison, L, κ.ά.
Έκδοση: (2008) -
Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
ανά: Suhana Bedi, κ.ά.
Έκδοση: (2022-01-01) -
Editorial: Personalized therapies for monogenic diabetes
ανά: Maurizio Delvecchio, κ.ά.
Έκδοση: (2024-09-01)